| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 19,818,300 | 21,193,200 | 19,284,900 | | Cost of Revenue | 17,900,100 | 16,473,900 | 14,930,700 | | | Gross Profit | 1,918,200 | 4,719,300 | 4,354,200 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 301,800 | 2,736,300 | 2,456,500 | | Non Recurring | 1,942,900 | 22,500 | (27,300) | | Others | 651,600 | 626,100 | 591,500 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (978,100) | 1,334,400 | 1,333,500 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (65,500) | 208,700 | 81,600 | | Earnings Before Interest And Taxes | (1,043,600) | 1,543,100 | 1,415,100 | | Interest Expense | 349,100 | 292,400 | 315,500 | | Income Before Tax | (1,392,700) | 1,250,700 | 1,099,600 | | Income Tax Expense | (78,300) | 428,300 | 351,000 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,314,400) | 822,400 | 748,600 | | | Non-recurring Events | | Discontinued Operations |
-
| (900) | 187,800 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (1,314,400) | 821,500 | 936,400 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,314,400) | $821,500 | $936,400 |
|
1.48% Nasdaq 
Income Statement
